Probiotics and necrotizing enterocolitis

Clinics in Perinatology

Volumn 41, Issue 4, 2014, Pages 967-978

  Neu, Josef ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Dysbiosis; Necrotizing enterocolitis; Pathophysiology; Probiotics

Indexed keywords

MYELOID DIFFERENTIATION FACTOR 88; PREBIOTIC AGENT; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADAPTIVE IMMUNITY; ANTIBIOTIC SENSITIVITY; BACTEROIDETES; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE PREDISPOSITION; DRUG EFFICACY; DRUG SAFETY; ESCHERICHIA COLI; FIRMICUTES; FOOD SAFETY; GASTROINTESTINAL TRACT; GOOD MANUFACTURING PRACTICE; HUMAN; HYDROLYSIS; IMMUNOREACTIVITY; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS REUTERI; LYMPHOCYTOPOIESIS; METABOLOMICS; NECROTIZING ENTEROCOLITIS; NONHUMAN; PROTEOBACTERIA; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS; BREAST MILK; ENTEROCOLITIS, NECROTIZING; INTESTINE; MICROBIOLOGY; MICROFLORA; NEWBORN; PREMATURITY;

ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTESTINES; MICROBIOTA; MILK, HUMAN; PROBIOTICS;

EID: 84911007842     PISSN: 00955108     EISSN: 15579840     Source Type: Journal    
DOI: 10.1016/j.clp.2014.08.014     Document Type: Review

References (84)

1. Neu J., Walker W.A. Necrotizing enterocolitis. NEngl J Med 2011, 364:255-264.
2. Sharma R., Hudak M.L. Aclinical perspective of necrotizing enterocolitis: past, present, and future. Clin Perinatol 2013, 40:27-51.
3. Lin P.W., Stoll B.J. Necrotising enterocolitis. Lancet 2006, 368:1271-1283.
4. Fitzgibbons S.C., Ching Y., Yu D., et al. Mortality of necrotizing enterocolitis expressed by birth weight categories. JPediatr Surg 2009, 44:1072-1076.
5. Pike K., Brocklehorst P., Jones D., et al. Outcomes at 7 years for babies who developed neonatal necrotising enterocolitis: the ORACLE Children Study. Arch Dis Child Fetal Neonatal Ed 2012, 97:F318-F322.
6. Bisquera J.A., Cooper T.R., Berseth C.L. Impact of necrotizing enterocolitis on length of stay and hospital charges in very low birth weight infants. Pediatrics 2002, 109:423-428.
7. Obladen M. Necrotizing enterocolitis-150 years of fruitless search for the cause. Neonatology 2009, 96:203-210.
8. Brown E.G., Sweet A.Y. Preventing necrotizing enterocolitis in neonates. JAMA 1978, 240:2452-2454.
9. LaGamma E.F., Ostertag S.G., Birenbaum H. Failure of delayed oral feedings to prevent necrotizing enterocolitis. Results of study in very-low-birth-weight neonates. Am J Dis Child 1985, 139:385-389.
10. Hay W.W. Aggressive nutrition of the preterm infant. Curr Pediatr Rep 2013, 1.
11. Jacobi S.K., Odle J. Nutritional factors influencing intestinal health of the neonate. Adv Nutr 2012, 3:687-696.
12. Terrin G., Passariello A., Canani R.B., et al. Minimal enteral feeding reduces the risk of sepsis in feed-intolerant very low birth weight newborns. Acta Paediatr 2009, 98:31-35.
13. Taylor S.N., Kiger J., Finch C., et al. Fluid, electrolytes, and nutrition: minutes matter. Adv Neonatal Care 2010, 10:248-255.
14. Ahle M., Drott P., Andersson R.E. Epidemiology and trends of necrotizing enterocolitis in Sweden: 1987-2009. Pediatrics 2013, 132:e443-e451.
15. Gordon P.V., Attridge J.T. Understanding clinical literature relevant to spontaneous intestinal perforations. Am J Perinatol 2009, 26:309-316.
16. Bell M.J., Ternberg J.L., Feigin R.D., et al. Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging. Ann Surg 1978, 187:1-6.
17. Anand R.J., Leaphart C.L., Mollen K.P., et al. The role of the intestinal barrier in the pathogenesis of necrotizing enterocolitis. Shock 2007, 27:124-133.
18. Hackam D.J., Good M., Sodhi C.P. Mechanisms of gut barrier failure in the pathogenesis of necrotizing enterocolitis: toll-like receptors throw the switch. Semin Pediatr Surg 2013, 22:76-82.
19. Claud E.C., Walker W.A. Hypothesis: inappropriate colonization of the premature intestine can cause neonatal necrotizing enterocolitis. FASEB J 2001, 15:1398-1403.
20. Wang Y., Hoenig J.D., Qamar S., et al. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J 2009, 3:944-954.
21. Mai V., Young C.M., Ukhanova M., et al. Fecal microbiota in premature infants prior to necrotizing enterocolitis. PLoS One 2011, 6:e20647.
22. Torrazza R.M., Ukhanova M., Wang X., et al. Intestinal microbial ecology and environmental factors affecting necrotizing enterocolitis. PLoS One 2013, 8:e83304.
23. Neu J. Neonatal necrotizing enterocolitis: an update. Acta Paediatr Suppl 2005, 94:100-105.
24. Hyman P.E., Clarke D.D., Sonne B., et al. Gastric acid secretory function in preterm infants. JPediatr 1985, 106:467-471.
25. Guillet R., Stoll B.J., Cotton C.M., et al. Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2006, 117:e137-e142.
26. Terrin G., Passariello A., DeCurtis M., et al. Ranitidine is associated with infections, necrotizing enterocolitis, and fatal outcome in newborns. Pediatrics 2012, 129:e40-e45.
27. Duncan S.H., Louis P., Thomson J.M., et al. The role of pH in determining the species composition of the human colonic microbiota. Environ Microbiol 2009, 11:2112-2122.
28. Petrof E.O., Claud E.C., Gloor G.B., et al. Microbial ecosystems therapeutics: a new paradigm in medicine?. Benef Microbes 2013, 4:53-65.
29. Turnbaugh P.J., Ley R.E., Hamady M., et al. The human microbiome project. Nature 2007, 449:804-810.
30. Keller M., Zengler K. Tapping into microbial diversity. Nature reviews. Microbiology 2004, 2:141-150.
31. Song S., Jarvie T., Hattori M. Our second genome-human metagenome: how next-generation sequencer changes our life through microbiology. Adv Microb Physiol 2013, 62:119-144.
32. Leonel A.J., Alvarez-Leite J.I. Butyrate: implications for intestinal function. Curr Opin Clin Nutr Metab Care 2012, 15:474-479.
33. Chang P.V., Hao L., Offermanns S., et al. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci USA 2014, 111:2247-2252.
34. Greenwood C., Morrow A.L., Lagomarcino A.J., et al. Early empiric antibiotic use in preterm infants is associated with lower bacterial diversity and higher relative abundance of enterobacter. JPediatr 2014, 165:23-29.
35. Cotten C.M., Taylor S., Stoll B., et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 2009, 123:58-66.
36. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118:229-241.
37. Russell S.L., Gold M.J.K., Willing B.P., et al. Perinatal antibiotic treatment affects murine microbiota, immune responses and allergic asthma. Gut Microbes 2013, 4:158-164.
38. Schumann A., Nutten S., Donnicola D., et al. Neonatal antibiotic treatment alters gastrointestinal tract developmental gene expression and intestinal barrier transcriptome. Physiol Genomics 2005, 23:235-245.
39. Trasande L., Bluestein J., Liu M., et al. Infant antibiotic exposures and early-life body mass. Int J Obes (Lond) 2013, 37:16-23.
40. Meinzen-Derr J., Poindexter B., Wrage L., et al. Role of human milk in extremely low birth weight infants' risk of necrotizing enterocolitis or death. JPerinatol 2009, 29:57-62.
41. Neville M.C., Anderson S.M., McManaman J.L., et al. Lactation and neonatal nutrition: defining and refining the critical questions. JMammary Gland Biol Neoplasia 2012, 17:167-188.
42. Hunt K.M., Foster J.A., Forney L.J., et al. Characterization of the diversity and temporal stability of bacterial communities in human milk. PLoS One 2011, 6:e21313.
43. Jeurink P.V., Bergenhenegouwan J., Jimenez E., et al. Human milk: a source of more life than we imagine. Benef Microbes 2013, 4:17-30.
44. Rijkers G.T., de Vos W.M., Brummer R.J., et al. Health benefits and health claims of probiotics: bridging science and marketing. Br J Nutr 2011, 106:1291-1296.
45. Reuman P.D., Duckworth D.H., Smith K.L., et al. Lack of effet of Lactobacillus on gastrointestinal bacterial colonization in premature infants. Pediatr Infect Dis 1986, 5:663-668.
46. Mihatsch W.A., Duckworth D.H., Smith K.L., et al. Critical systematic review of the level of evidence for routine use of probiotics for reduction of mortality and prevention of necrotizing enterocolitis and sepsis in preterm infants. Clin Nutr 2012, 31:6-15.
47. Deshpande G., Rao S., Patole S., et al. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 2010, 125:921-930.
48. Jacobs S.E., Tobin S.E., Opie G.F., et al. Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial. Pediatrics 2013, 132:1055-1062.
49. Rojas M.A., Lozano J.M., Rojas M.X., et al. Prophylactic probiotics to prevent death and nosocomial infection in preterm infants. Pediatrics 2012, 130:e1113-e1120.
50. Deshpande G., Rao S., Patole S. Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials. Lancet 2007, 369:1614-1620.
51. Tarnow-Mordi W.O., Wilkinson D., Trived I.A., et al. Probiotics reduce all-cause mortality in necrotizing enterocolitis: it is time to change practice. Pediatrics 2010, 125(5):1068-1070.
52. Soll R.F. Probiotics: are we ready for routine use?. Pediatrics 2010, 125:1071-1072.
53. Murguia-Peniche T., Mihatsch W.A., Zegerra J., et al. Intestinal mucosal defense system, Part 2. Probiotics and prebiotics. JPediatr 2013, 162:S64-S71.
54. Caplan M. Are probiotics ready for prime time?. JPEN J Parenter Enteral Nutr 2012, 36:6S.
55. Neu J., Mihatsch W. Recent developments in necrotizing enterocolitis. JPEN J Parenter Enteral Nutr 2012, 36:30S-35S.
56. Alfaleh K., Anabrees J., Bassler D., et al. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2011, (3). CD005496.
57. Lin H.C., Hsu C.H., Chen H.L., et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 2008, 122:693-700.
58. Azad M.B., Konya T., Maughan H., et al. Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. CMAJ 2013, 185:385-394.
59. Jakobsson H.E., Abrahamsson T.R., Jenmaier M.C., et al. Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by Caesarean section. Gut 2014, 63:559-566.
60. McClave S.A., Heyland D.K., Wischmeyer P.E. Comment on: probiotic prophylaxis in predicted severe acute pancreatitis: a randomized, double-blind, placebo-controlled trial. JPEN J Parenter Enteral Nutr 2009, 33:444-446.
61. Cilieborg M.S., Thymann T., Siggers R., et al. The incidence of necrotizing enterocolitis is increased following probiotic administration to preterm pigs. JNutr 2011, 141:223-230.
62. Shanahan F. Acommentary on the safety of probiotics. Gastroenterol Clin North Am 2012, 41:869-876.
63. Neu J. Routine probiotics for premature infants: let's be careful!. JPediatr 2011, 158:672-674.
64. Modi N. Probiotics and necrotising enterocolitis: the devil (as always) is in the detail. Commentary on N. Ofek Shlomai etal.: probiotics for preterm neonates: what will it take to change clinical practice? (Neonatology 2014;105:64-70). Neonatology 2014, 105:71-73.
65. Claud E.C. First do no harm. JPediatr Pharmacol Ther 2012, 17:298-301.
66. Martin C.R. Probiotics for the prevention of necrotizing enterocolitis: not just which ones but also why?. JPediatr Gastroenterol Nutr 2013, 57:3.
67. Thomas D.W., Greer F.R. Probiotics and prebiotics in pediatrics. Pediatrics 2010, 126:1217-1231.
68. Braegger C., Chmielewska A., Decsi T., et al. Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition. JPediatr Gastroenterol Nutr 2011, 52:238-250.
69. Kataria J., Li N., Wynn J.L., et al. Probiotic microbes: do they need to be alive to be beneficial?. Nutr Rev 2009, 67:546-550.
70. Lopez M., Li N., Kataria J., et al. Live and ultraviolet-inactivated Lactobacillus rhamnosus GG decrease flagellin-induced interleukin-8 production in Caco-2 cells. JNutr 2008, 138:2264-2268.
71. Mazmanian S.K., Round J.L., Kasper D.L. Amicrobial symbiosis factor prevents intestinal inflammatory disease. Nature 2008, 29:620-625.
72. Antonowicz I., Lebenthal E. Developmental pattern of small intestinal enterokinase and disaccharidase activities in the human fetus. Gastroenterology 1977, 72:1299-1303.
73. Kien C.L., McClead R.E., Cordero L.J. Effects of lactose intake on lactose digestion and colonic fermentation in preterm infants. JPediatr 1998, 133:401-405.
74. Kien C.L., Chang J.C., Cooper J.R. Quantitation of colonic luminal synthesis of butyric acid in piglets. JPediatr Gastroenterol Nutr 2002, 35:324-328.
75. Lifschitz C. Prevention of excessive crying by intestinal microbiota programming. JPediatr 2013, 163:1250-1252.
76. Shamir R., St.James-Roberts I., DiLorenzo C., et al. Infant crying, colic, and gastrointestinal discomfort in early childhood: a review of the evidence and most plausible mechanisms. JPediatr Gastroenterol Nutr 2013, 57(Suppl 1):S1-S45.
77. Ruhaak L.R., Lebrilla C.B. Analysis and role of oligosaccharides in milk. BMB Rep 2012, 45:442-451.
78. Newburg D.S., Grave G. Recent advances in human milk glycobiology. Pediatr Res 2014, 75:675-679.
79. Manthey C.F., Autran C.A., Eckmann L., et al. Human milk oligosaccharides protect against enteropathogenic escherichia coli attachment invitro and EPEC colonization in suckling mice. JPediatr Gastroenterol Nutr 2014, 58:167-170.
80. Li M., Monaco M.H., Wang M., et al. Human milk oligosaccharides shorten rotavirus-induced diarrhea and modulate piglet mucosal immunity and colonic microbiota. ISME J 2014, 8:1609-1620.
81. Cammarota G., Ianiro G., Gasbarrini A. Fecal microbiota transplantation for the treatment of clostridium difficile infection: a systematic review. JClin Gastroenterol 2014, 48:693-702.
82. Nitzan O., Elias M., Chazan B., et al. Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment. World J Gastroenterol 2013, 19:7577-7585.
83. van Nood E., Speelman P., Nieuwdorp M., et al. Fecal microbiota transplantation: facts and controversies. Curr Opin Gastroenterol 2014, 30:34-39.
84. Smits L.P., Bouter K.E., de Vos W.M., et al. Therapeutic potential of fecal microbiota transplantation. Gastroenterology 2013, 145:946-953.